jiangsu hengrui medicine co ltd
X-BODY, Jiangsu Hengrui To Develop Novel Therapeutic Antibodies
X-BODY Biosciences has signed an agreement with Jiangsu Hengrui to commercialize therapeutic antibodies for age-related macular degeneration.



